SCHEMBL5676145

SCHEMBL5676145

CCCCCc1cc(CCC)c(CCC)c(O)c1OC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.42
PTGES O14684 2/20 0.39
TOP2A P11388 1/20 0.39
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
PPARD Q03181 1/20 0.39
PTGS2 P35354 3/20 0.38
CNR2 P34972 1/20 0.37
BID P55957 3/20 0.37
MCL1 Q07820 3/20 0.37
BCL2L1 Q07817 2/20 0.37
BAK1 Q16611 2/20 0.37
KAT8 Q9H7Z6 2/20 0.37
EP300 Q09472 1/20 0.37
KAT2A Q92830 1/20 0.37
KAT2B Q92831 1/20 0.37
KAT5 Q92993 1/20 0.37
SAE1 Q9UBE0 1/20 0.37
SLC6A3 Q01959 1/20 0.37
TRPM7 Q96QT4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678605 1.00 ALOX5 (0.42) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5678629 0.99 ALOX5 (0.43) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5680282 0.97 ALOX5 (0.42) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5677030 0.97 ALOX5 (0.42) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5680727 0.96 ALOX5 (0.41) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5848804 0.96 ALOX5 (0.40) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5920266 0.96 PPARG (0.38) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5677012 0.94 ALOX5 (0.38) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5680719 0.94 ALOX5 (0.44) ALOX5PTGESTOP2APPARGPPARA
SCHEMBL5678562 0.93 ALOX5 (0.43) ALOX5PTGESTOP2APPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR ALOX5 833/4885PTGES 525/4885TOP2A 4237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.